Description
Introduction
In this analysis, Datamonitor estimates that there were a total of 53 million cases of insomnia in 2010 in the seven major markets with nearly a half of these cases present in the US. Prevalence rates for insomnia are expected to remain constant; therefore, any changes in prevalence will depend on population dynamics in the seven major healthcare markets
Features and benefits
• Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent insomnia cases.
• Understand the key epidemiologic risk factors associated with insomnia.
Highlights
Datamonitor expects an increase in prevalent insomnia cases in the next decade in the seven major markets as a result of an ageing population.
Unsatisfactory sleep can cause severe distress and cause social, interpersonal, and occupational impairment.
Your key questions answered
• What are the most robust epidemiologic studies for insomnia prevalence data?
• How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
• How do changes in population structure and risk factors affect the trend in prevalent insomnia cases?
Table of Contents
Executive Summary
Insomnia prevalence driven by aging populations
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Definition of insomnia
Diagnostic criteria
GLOBAL VARIATION AND HISTORICAL TRENDS
Evolving insomnia definition resulted in variable prevalence rates
Prevalence: secondary prevalence caused by mental disorders is most common
Incidence: acute insomnia of short duration is not clinically considered
CO-MORBIDITIES
Insomniacs often suffer from psychiatric disorders, medical conditions, and physical pain
RISK FACTORS
Age and gender
Age: insomnia prevalence increases with advancing age
Gender: insomnia is more prevalent in females than males
Mental and physical conditions
Mental health conditions pose the greatest risk factor for insomnia
Physical condition: pain is the most common physical cause of insomnia
Medical conditions: bidirectional causality
EPIDEMIOLOGIC FORECASTING OF INSOMNIA
Sources of epidemiologic data
Description of methods
US
Japan
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Estimated prevalent cases of insomnia and future trends
Segmentation of prevalent cases
DISCUSSION
Strengths and limitations
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX
Report methodology
